Dianomi Therapeutics
Parker
About Dianomi Therapeutics
Dianomi Therapeutics is a development stage biopharmaceutical company focused on improving the delivery and efficacy of large and small molecules in the treatment of inflammatory diseases. With an initial focus on osteoarthritis and rheumatoid arthritis, They are working to enhance the safety, efficacy, and duration of effect of therapeutic agents by incorporating them with Thier proprietary mineral coated microparticle system (MCM).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.2M
- Last round: Corporate Round (Feb 2019)
- Website: dianomitx.com
- Phone: 303-880-9590
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/dianomi-therapeutics-18009 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.